Tag: Paxlovid rebound
FDA on Paxlovid rebound: “there is no evidence of benefit at this time for a longer course of treatment”
The US FDA have issued a thinly veiled rebuke to Pfizer CEO Albert Bourla, after his recent comments to Bloomberg News about Covid-19 infections rebounding after treatment with Paxlovid.… ...More...
Paxlovid: Virologic characterization of nirmatrelvir-ritonavir rebound
“Symptomatic relapse after nirmatrelvir-ritonavir therapy for early stage COVID-19 infection is associated with high viral load.”…… ...More...
Paxlovid: Covid-19 infections rebounding a few days after treatment *4 UPDATES*
There are some anecdotal reports on social media today about Covid-19 infections rebounding a few days after taking Paxlovid.… ...More...